Videos | Heart Failure

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at Mass General Hospital ...

Home November 15, 2018
Home
Videos | EP Lab

Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate ...

Home November 15, 2018
Home
News | Cardiac Diagnostics

The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines for Americans at the American Heart Association’s (AHA) 2018 Scientific Sessions, Nov. 10-12 in Chicago. The second edition — announced at AHA by Adm. Brett P. Giroir, M.D., assistant secretary for health — provides evidence-based recommendations for youth ages three through 17 and adults to safely get the physical activity they need to stay healthy.

Home November 14, 2018
Home
Videos | Artificial Intelligence

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at Mass General Hospital ...

Home November 14, 2018
Home
Videos | Computed Tomography (CT)

Matthew Budoff, M.D., professor of medicine, David Geffen School of Medicine, UCLA, spoke at the 2018 American Heart ...

Home November 14, 2018
Home
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics

November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of ...

Home November 13, 2018
Home
Videos | Pharmaceuticals

Deepak L. Bhatt, M.D., executive director of the interventional cardiovascular program, Brigham and Women’s Hospital ...

Home November 13, 2018
Home
News | Pharmaceuticals

A study in the current edition of the New England Journal of Medicine shows that a particular treatment significantly reduced cardiovascular events, including cardiovascular death, in patients who continue to have high triglyceride levels on statin therapy. These findings could lead to a more effective and life-saving treatment option when used with other combinations of drugs to treat cardiovascular disease.

Home November 13, 2018
Home
News | Hypertension

Black adults experience dangerous spikes in high blood pressure, called a hypertensive crisis, at a rate that is five times the national average, according to a new study. The study was presented at the American Heart Association’s (AHA) Joint Hypertension 2018 Scientific Sessions, an annual conference focused on recent advances in hypertension research, Sept. 6-9 in Chicago.

Home November 13, 2018
Home
News | Vascular Closure Devices

The Vascade MVP vascular closure system met its endpoints compared to manual compression in a pivotal clinical study for multi-access venous closure following electrophysiology (EP) procedures, according to manufacturer Cardiva Medical Inc. The AMBULATE study is the first randomized pivotal trial of vessel closure conducted exclusively by EP physicians.

Home November 11, 2018
Home
News | Artificial Intelligence

At the American Heart Association’s (AHA) Scientific Sessions 2018, Nov. 10-12 in Chicago, Eko presented a clinical study abstract revealing the first murmur detection algorithm to outperform the majority of participating cardiologists. Entitled “Artificial Intelligence Detects Pediatric Heart Murmurs With Cardiologist-Level Accuracy,” the study demonstrates the power of machine learning and artificial intelligence (AI) to enhance cardiac care.

Home November 11, 2018
Home
News | Wearables

Wearable cardiac biosensor developer Cardiac Insight Inc. has partnered with VivoSense, specializing in integration and specialized analysis of wearable sensor data for research and clinical trials. Together, both companies will deliver enhanced research analytics to help VivoSense expand the use of wearable biosensors for pharmaceutical clinical trials and other healthcare applications.

Home November 09, 2018
Home
News | Peripheral Artery Disease (PAD)

November 9, 2018 — VentureMed Group Inc. announced the initiation of a new study to determine if the Flex Dynamic ...

Home November 09, 2018
Home
News | EP Lab

The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS) released a guideline for the evaluation and treatment of patients with bradycardia, or a slow heartbeat, and cardiac conduction disorders.

Home November 09, 2018
Home
News | Peripheral Artery Disease (PAD)

The Lutonix Drug-Coated Balloon (DCB) showed statistically significant safety equivalence with a standard percutaneous transluminal angioplasty (PTA) catheter for the treatment of narrowed or obstructed arteries below the knee in recent trial results. The data were presented at the Vascular Interventional Advances (VIVA) 2018 annual conference, Nov. 5-8 in Las Vegas.

Home November 07, 2018
Home
Subscribe Now